Vimarsana
Biggest News Aggregation in the World

Page 6 - David Cory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Cory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Cory Today - Breaking & Trending Today

Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies - Vimarsana News

Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

First and only treatment approved in Europe to treat Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies1Extende...

Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022 - Vimarsana News

Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

Eiger BioPharmaceuticals Enters into $75M Term Loan Agreement and $5M Stock Purchase Agreement with Innovatus Capital Partners to Refinance Existing Debt Facility and Further Strengthen Cash Posit... - Vimarsana News

Eiger BioPharmaceuticals Enters into $75M Term Loan Agreement and $5M Stock Purchase Agreement with Innovatus Capital Partners to Refinance Existing Debt Facility and Further Strengthen Cash Posit...

Eiger nets approximately $11M after retiring its existing debt facilityImmediately bolsters cash position and provides access to an additional $35...

Eiger BioPharmaceuticals to Present at the Jefferies Global Healthcare Conference - Vimarsana News

Eiger BioPharmaceuticals to Present at the Jefferies Global Healthcare Conference

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...